Environmental, Social And Governance Report

Overview

The report describes Hua Medicine's 2021 ESG governance, with the Board overseeing ESG matters and senior management and the EHS department implementing related work. It highlights acceptance of the dorzagliatin NDA by China's NMPA and the construction of an industrialization base in Shanghai. The report also states that there were no work-related injuries or deaths in the company during the past three years.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services